Investor Relations Captor Therapeutics ®
Quarterly report for III quarter 2023
The documents posted on this website are translated versions of the original reports issued in Polish. These documents have been prepared only for informational purposes. Only the original versions of these reports are binding.
Attachments:
1) Interim Condensed Consolidated and Separate Financial Statements prepared for the three months ended September 30, 2023 (pdf)
2) Extended Consolidated Quarterly Report of the Group for the period 1 January 2023 - 30 September 2023 (pdf)